首页 产品目录 全部产品 帕妥珠单抗

帕妥珠单抗

Pertuzumab

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

380610-27-5

中文名称

帕妥珠单抗

英文名称

Pertuzumab

别名

pertuzumab;2C4;Immunoglobulin G1, anti-(human V (receptor)) (human-mouse monoclonal 2C4 heavy chain), disulfide with human-mouse monoclonal 2C4 kappa-chain, dimer;Omnitarg;Unii-K16aiq8ctm;Pertuzumab (anti-HER2);Pertuzumab-Perjeta;Research Grade Pertuzumab(DHC09602)

MDL No.

MFCD08436787

用途

Pertuzumab is indicated for: (1) use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer (MBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease; (2) use in combination with trastuzumab and docetaxel as neoadjuvant therapy for patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer (tumor diameter >2 cm or node-positive) as part of a complete treatment regimen for early breast cancer, based on pathological complete response rate; (3) use in combination with trastuzumab and chemotherapy as adjuvant therapy for patients with HER2-positive early breast cancer at high risk of recurrence.

安全信息

评论 0
我是晶智Agent,
您的化学小助手